Reversible cognitive and neurological symptoms during valproic acid therapy.
Hommet
Caroline
C
Mondon
Karl
K
de Toffol
Bertrand
B
Constans
Thierry
T
D000369:Aged, 80 and over; D000927:Anticonvulsants / Q000009:adverse effects*; D001259:Ataxia / Q000139:chemically induced; D003072:Cognition Disorders / Q000139:chemically induced; D006801:Humans; D008297:Male; D012640:Seizures / Q000188:drug therapy*; D014635:Valproic Acid / Q000009:adverse effects*
D000927:Anticonvulsants; D014635:Valproic Acid